ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
Dow Jones
44,546.08
-0.37%
US Dollar vs MXN
20.3062
0.00%
Brent Oil
74.165
-0.30%
Bitcoin
96,132.33
-1.50%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) Noticias

CUE

Cue Biopharma (CUE)

Cue Biopharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CUE
FechaHoraFuenteTítuloSímboloCompañía
03/01/202515:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
29/11/202415:30GlobeNewswire Inc.Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CUECue Biopharma Inc
29/11/202415:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
25/11/202407:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
14/11/202415:05GlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
14/11/202415:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
14/11/202415:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
14/11/202407:00GlobeNewswire Inc.Cue Biopharma Announces Strategic Organizational TransitionNASDAQ:CUECue Biopharma Inc
12/11/202407:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
08/11/202412:30GlobeNewswire Inc.Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
07/10/202416:07Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CUECue Biopharma Inc
04/10/202408:00GlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
27/09/202415:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CUECue Biopharma Inc
26/09/202422:26GlobeNewswire Inc.Cue Biopharma Announces Pricing of $12.0 Million Public OfferingNASDAQ:CUECue Biopharma Inc
26/09/202422:10GlobeNewswire Inc.Cue Biopharma Announces Proposed Public OfferingNASDAQ:CUECue Biopharma Inc
10/09/202415:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CUECue Biopharma Inc
09/09/202407:00GlobeNewswire Inc.Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business OfficerNASDAQ:CUECue Biopharma Inc
03/09/202407:00GlobeNewswire Inc.Cue Biopharma to Present at The Promise of Interleukin-2 Therapy ConferenceNASDAQ:CUECue Biopharma Inc
28/08/202415:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CUECue Biopharma Inc
19/08/202415:05GlobeNewswire Inc.Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
13/08/202407:00GlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
25/07/202415:05GlobeNewswire Inc.Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital RequirementsNASDAQ:CUECue Biopharma Inc
04/06/202407:00GlobeNewswire Inc.Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual MeetingNASDAQ:CUECue Biopharma Inc
03/06/202407:00GlobeNewswire Inc.Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024NASDAQ:CUECue Biopharma Inc
24/05/202415:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CUECue Biopharma Inc
09/05/202415:05GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
08/05/202407:00GlobeNewswire Inc.Cue Biopharma to Present at the 20th Annual PEGS Boston SummitNASDAQ:CUECue Biopharma Inc
07/05/202407:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
24/04/202409:01GlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
08/04/202415:05GlobeNewswire Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsNASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BNPQY
BNP Paribas (QX)
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
CCOM
US500
US 500
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
USOTC
RHHBY
Roche (QX)
COIN
XRPUSD
Ripple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios